• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adjuvant immunotherapy for cancer: the next step.

作者信息

Sondak Vernon K, McArthur Grant A

机构信息

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA.

Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia.

出版信息

Lancet Oncol. 2015 May;16(5):478-80. doi: 10.1016/S1470-2045(15)70162-2. Epub 2015 Mar 31.

DOI:10.1016/S1470-2045(15)70162-2
PMID:25840692
Abstract
摘要

相似文献

1
Adjuvant immunotherapy for cancer: the next step.癌症辅助免疫疗法：下一步发展
Lancet Oncol. 2015 May;16(5):478-80. doi: 10.1016/S1470-2045(15)70162-2. Epub 2015 Mar 31.
2
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.辅助伊匹单抗对比安慰剂用于完全切除的高风险 III 期黑色素瘤（EORTC 18071）：一项随机、双盲、III 期临床试验。
Lancet Oncol. 2015 May;16(5):522-30. doi: 10.1016/S1470-2045(15)70122-1. Epub 2015 Mar 31.
3
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials.局部低剂量 CpG-B 辅助治疗可持久预防临床 I 期- II 期黑色素瘤疾病复发：两项随机 II 期试验数据。
Clin Cancer Res. 2017 Oct 1;23(19):5679-5686. doi: 10.1158/1078-0432.CCR-17-0944.
4
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.重组人粒细胞巨噬细胞集落刺激因子（GM-CSF，沙格司亭）作为II期（T4）、III期和IV期黑色素瘤的辅助治疗用药3年。
J Immunother. 2009 Jul-Aug;32(6):632-7. doi: 10.1097/CJI.0b013e3181a7d60d.
5
[Medical therapy of malignant melanoma].[恶性黑色素瘤的医学治疗]
Ann Ital Chir. 1989 Jul-Aug;60(4):257-63.
6
Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.载有抗原和佐剂的脂质体包覆的金纳米笼靶向递送至树突状细胞，增强抗肿瘤免疫反应。
Biomaterials. 2017 Dec;149:41-50. doi: 10.1016/j.biomaterials.2017.09.029. Epub 2017 Sep 26.
7
[Trials of (poly A. poly U) adjuvant immunotherapy in breast cancer treatment].（聚腺苷酸-聚尿苷酸）佐剂免疫疗法在乳腺癌治疗中的试验
Bull Cancer. 1974 Apr-Jun;61(2):275-80.
8
Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.外用5%咪喹莫特乳膏辅助治疗Ⅲb期黑色素瘤切除术后患者。
Eur J Dermatol. 2011 May-Jun;21(3):410-1. doi: 10.1684/ejd.2011.1282.
9
Adjuvant therapy for melanoma: a surgical perspective.黑色素瘤的辅助治疗：外科视角
Surg Oncol Clin N Am. 2011 Jan;20(1):105-14. doi: 10.1016/j.soc.2010.09.001.
10
Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.用二苯环丙烯酮联合达卡巴嗪及放疗进行局部免疫治疗黑色素瘤皮肤转移灶。
Dermatology. 2005;211(4):370-1. doi: 10.1159/000088512.

引用本文的文献

1
Immune-related [F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications.免疫相关 [F]FDG PET 研究在接受检查点抑制剂治疗的患者中的发现：与临床不良事件的相关性及预后意义。
Cancer Imaging. 2024 Sep 17;24(1):125. doi: 10.1186/s40644-024-00774-9.
2
Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin.接受免疫检查点抑制剂和阿霉素联合治疗的患者的癌症治疗相关心脏功能障碍
Cancers (Basel). 2022 May 7;14(9):2320. doi: 10.3390/cancers14092320.
3
PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction.
PD-1 抑制剂诱导细胞外体 miR-34a-5p 表达，介导免疫检查点抑制剂相关心脏功能障碍中心肌细胞与巨噬细胞的串扰。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001293.
4
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.免疫疗法对接受胰腺肿瘤根治性手术的胰腺腺癌患者生存的影响：国家癌症数据库的回顾性分析。
Radiat Oncol. 2020 Jun 3;15(1):139. doi: 10.1186/s13014-020-01569-5.
5
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.全球应变与免疫检查点抑制剂相关心肌炎患者的心脏事件。
J Am Coll Cardiol. 2020 Feb 11;75(5):467-478. doi: 10.1016/j.jacc.2019.11.049.
6
Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab.在给予第一剂度伐鲁单抗时出现急性起病的肺炎。
Case Rep Oncol. 2019 Aug 6;12(2):621-624. doi: 10.1159/000502202. eCollection 2019 May-Aug.
7
Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy.靶向药物和免疫治疗时代III期黑色素瘤的辅助治疗
Melanoma Manag. 2016 Jun;3(2):137-147. doi: 10.2217/mmt-2016-0002. Epub 2016 May 25.
8
Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis.评价抗阻训练对新辅助和辅助治疗的癌症患者改善肌肉力量和身体成分的作用：一项荟萃分析。
J Cancer Surviv. 2017 Jun;11(3):339-349. doi: 10.1007/s11764-016-0592-x. Epub 2017 Jan 4.